NHMRC Glaucoma Guidelines - ANZGIG

More documents

Recommendations

Info

NHMRC GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA Chapter 8 – Monitoring: long-term care serious short-term post-operative complications. Hospitalisation may also be indicated for patients in whom surgical complications have occurred or for patients who have special medical or social needs. Children with suspected glaucoma should be immediately referred to a specialist ophthalmologist and may need to be anaesthetised for assessment. Patients should be informed about which health care provider is responsible for particular aspects of their glaucoma care. Referral Using established networks, primary health care providers are encouraged to engage with an ophthalmologist when a glaucoma diagnosis is suspected or confirmed. Various formal and ad-hoc relationships between general practitioners, nurses, ophthalmologists, optometrists and orthoptists exist around the country to maximise the use of diagnostic resources which should be encouraged. Close cooperation between optometrists and ophthalmologists should provide an optimal environment for the management of glaucoma. This may vary according to the patient’s location and the cooperation may involve optometric and general practice treatment initiation with ophthalmologist follow up especially where ready access to an ophthalmologist is not available. Cooperation between all three professional groups is recommended for all patients diagnosed with glaucoma. Patients with significant visual impairment or blindness should be referred to, and encouraged to use, appropriate vision rehabilitation and social services to enhance their quality of life and independence. Questions to ask your patient with glaucoma at review How are you? How are your eyes and vision? Are you managing to take your medication as discussed? If no, what are the problems and difficulties you face? Is there anything about your condition or your treatment plan that you would like explained? Are you experiencing any side effects from the medication? Do you have other medical conditions? If yes, have they been exacerbated recently? Are you taking any prescription or over-the-counter medicines, if so what? Do you have plans to conceive/are you already pregnant? If yes, do you plan to breastfeed? When did you last attend an eye examination or have your condition monitored? References American Academy of Ophthalmology [AAO] (2005a): Primary angle closure preferred practice pattern. San Francisco: American Academy of Ophthalmology. American Academy of Ophthalmology [AAO] (2005b): Primary open-angle glaucoma preferred practice pattern. San Francisco: American Academy of Ophthalmology. American Academy of Ophthalmology [AAO] (2005c): Primary open-angle glaucoma suspect preferred practice pattern. San Francisco: American Academy of Ophthalmology. American Optometric Association [AOA] (2002): Optometric clinical practice guideline: Care of the patient with open angle glaucoma (2nd edn.). St Louis: American Optometric Association. National Health and Medical Research Council 105
NHMRC GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA Chapter 8 – Monitoring: long-term care Artes PH, Chauhan BC, (2005): Longitudinal changes in the visual field and optic disc in glaucoma. Progress in Retinal and Eye Research; 24 333–354. Barry C,J Eikelboom R, Kanagasingam Y, Jitskaia L, Morgan W, House P, Cuypers M (2000): Comparison of optic disc image assessment methods when examining serial photographs for glaucomatous progression. British Journal of Ophthalmology; 84:28–30. Burgoyne CF (2004): Image analysis of optic nerve disease. Eye; 18: 1207–1213. Canadian Glaucoma Study Group (2006): Canadian glaucoma study: 1. Study design, baseline characteristics and preliminary analyses. Canadian Journal of Ophthalmology; 41:566-75. Chauhan BC, Garway-Heath DF, Goñi FJ, Rossetti L, Bengtsson B, Viswanathan AC, Heijl A (2008): Practical Recommendations for Measuring Rates of Visual Field Change in Glaucoma. British Journal of Ophthalmology; 92(4):569-73. Collaborative Normal-Tension Glaucoma Study Group [CNTGS] (1998): Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. American Journal of Ophthalmology; 126:487-97. European Glaucoma Society [EGS] (2003): Terminology and guidelines for glaucoma (2nd edn.). Savona, Italy: European Glaucoma Society. Gardiner SK, Crabb DP (2002): Frequency of testing for detecting visual field progression. British Journal of Ophthalmology; 86:560-564. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish II RK, Wilson MR, Kass MA (2002): The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma. Archives of Ophthalmology; 120: 714-720. Heigl A, Leske C, Bengtsson B, Hyman L, Bengtsson B, Hussien M (2002): Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Archives of Ophthalmology; 120:1268-1279. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Gordon MO (2002): A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of Ophthalmology; 120:701-713. Leske MC, Heijl A, Hyman L, Bengtsson B, Komaroff E (2004): Factors for progression and glaucoma treatment: The Early Manifest Glaucoma Trial. Current Opinion in Ophthalmology; 15:102–106. Optometrists Registration Board Victoria (2008): www.optomboard.vic.gov.au [Accessed August 2008]. South African Glaucoma Society [SAGS] (2006): Glaucoma algorithm and guidelines for glaucoma. Hatfield: South African Glaucoma Society. South-East Asia Glaucoma Interest Group [SEAGIG] (2003): Asia Pacific Glaucoma Guidelines. Sydney: South-East Asia Glaucoma Interest Group. Spry PGD, Johnson CA (2002): Identification of Progressive Glaucomatous Visual Field Loss. Survey of Ophthalmology; 47(2):158-173. 106 National Health and Medical Research Council
Page 1:
NHMRC Guidelines for the Screening,
Page 4 and 5:
NHMRC GUIDELINES FOR THE SCREENING,
Page 6 and 7:
Page 8:
Page 12 and 13:
Page 14:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 34 and 35:
Page 36 and 37:
Page 38:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62: NHMRC GUIDELINES FOR THE SCREENING,
Page 144: NHMRC GUIDELINES FOR THE SCREENING,
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 172 and 173:
Page 174:
Page 177 and 178:
Page 179 and 180:
Page 181:
show all

NHMRC Glaucoma Guidelines - ANZGIG

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?